Meta Pixel

News and Announcements

Walker Capital features in Sydney Morning Herald

  • Published March 20, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Highlights

  • With the Royal Banking Commission on the minds of Australian investors, people are looking towards more transparent options when it comes to investing their money.
  • 2018 figures show a 31 per cent increase in MDAs, bringing Australian funds under management in MDAs to a total of $62.43 billion.
  • Walker Capital focuses on giving investors more control and ownership of their investments though MDAs and real-time access to their accounts online.

With the Royal Banking Commission on the minds of Australian investors, people are looking towards more transparent options when it comes to investing their money. As a result, Managed Discretionary Accounts (MDAs) are becoming a more popular investment choice. 2018 figures show a 31 per cent increase, bringing Australian funds under management in MDAs to a total of $62.43 billion.

Michael Walker, Principal of Walker Capital has created an investment company that offers transparency and security to investors with a policy of digital onboarding when welcoming new investors. He focuses on giving investors more control and ownership of their investments though MDAs and real-time access to their accounts online.

Michael states there is a clear desire for investors to diversify and de-risk their portfolios through investments into alternative asset classes. MDAs allow for individual investors to have separate investment accounts, and with a balance of fundamental and technical analysis, Walker Capital aims to ‘balance the risks’ and bring a positive return to its investors.

 

About Walker Capital

Walker Capital is to raise up to $900,000 for 20% in equity. The capital will be used to fund the expansion of the Company as it increases its marketing campaign aimed at expanding its client base and developing an investment platform for its clients.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now